DUS1L and glioblastoma: To assess the capacity of DUS1L to mediate formation of D16 and potentially also D17 in human cytoplasmic tRNAs, DUS1L was knocked out in two glioblastoma cell lines (LNZ308 and U87) using the CRISPR/Cas9 system.